These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 35712978)

  • 1. Glymphatic dysfunction correlates with severity of small vessel disease and cognitive impairment in cerebral amyloid angiopathy.
    Xu J; Su Y; Fu J; Wang X; Nguchu BA; Qiu B; Dong Q; Cheng X
    Eur J Neurol; 2022 Oct; 29(10):2895-2904. PubMed ID: 35712978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired glymphatic system as evidenced by low diffusivity along perivascular spaces is associated with cerebral small vessel disease: a population-based study.
    Tian Y; Cai X; Zhou Y; Jin A; Wang S; Yang Y; Mei L; Jing J; Li S; Meng X; Wei T; Liu T; Wang Y; Pan Y; Wang Y
    Stroke Vasc Neurol; 2023 Oct; 8(5):413-423. PubMed ID: 37045543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between amyloid pathology, cerebral small vessel disease, glymphatic dysfunction, and cognition: a study based on Alzheimer's disease continuum participants.
    Hong H; Hong L; Luo X; Zeng Q; Li K; Wang S; Jiaerken Y; Zhang R; Yu X; Zhang Y; Lei C; Liu Z; Chen Y; Huang P; Zhang M;
    Alzheimers Res Ther; 2024 Feb; 16(1):43. PubMed ID: 38378607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total Magnetic Resonance Imaging Burden of Small Vessel Disease in Cerebral Amyloid Angiopathy: An Imaging-Pathologic Study of Concept Validation.
    Charidimou A; Martinez-Ramirez S; Reijmer YD; Oliveira-Filho J; Lauer A; Roongpiboonsopit D; Frosch M; Vashkevich A; Ayres A; Rosand J; Gurol ME; Greenberg SM; Viswanathan A
    JAMA Neurol; 2016 Aug; 73(8):994-1001. PubMed ID: 27366898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediators of cognitive impairment in cerebral amyloid angiopathy.
    Durrani R; Wang M; Cox E; Irving E; Saad F; McCreary CR; Beaudin AE; Gee M; Nelles K; Sajobi TT; Ismail Z; Camicioli R; Smith EE
    Int J Stroke; 2023 Jan; 18(1):78-84. PubMed ID: 35473418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging features of small vessel disease in cerebral amyloid angiopathy among patients with Alzheimer's disease.
    Nagaraja N; DeKosky S; Duara R; Kong L; Wang WE; Vaillancourt D; Albayram M
    Neuroimage Clin; 2023; 38():103437. PubMed ID: 37245492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertensive Arteriopathy and Cerebral Amyloid Angiopathy in Patients with Cognitive Decline and Mixed Cerebral Microbleeds.
    Ii Y; Ishikawa H; Matsuyama H; Shindo A; Matsuura K; Yoshimaru K; Satoh M; Taniguchi A; Matsuda K; Umino M; Maeda M; Tomimoto H
    J Alzheimers Dis; 2020; 78(4):1765-1774. PubMed ID: 33185609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glymphatic system impairment in Alzheimer's disease: associations with perivascular space volume and cognitive function.
    Zhang X; Wang Y; Jiao B; Wang Z; Shi J; Zhang Y; Bai X; Li Z; Li S; Bai R; Sui B
    Eur Radiol; 2024 Feb; 34(2):1314-1323. PubMed ID: 37610441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of Perivascular Space Markers With Incident Dementia in Cerebral Small Vessel Disease.
    Hong H; Tozer DJ; Markus HS
    Stroke; 2024 Apr; 55(4):1032-1040. PubMed ID: 38465597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perivascular Spaces, Diffusivity Along Perivascular Spaces, and Free Water in Cerebral Small Vessel Disease.
    Li H; Jacob MA; Cai M; Kessels RPC; Norris DG; Duering M; De Leeuw FE; Tuladhar AM
    Neurology; 2024 May; 102(9):e209306. PubMed ID: 38626373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Association Between Glymphatic System Dysfunction and Cognitive Impairment in Cerebral Small Vessel Disease.
    Tang J; Zhang M; Liu N; Xue Y; Ren X; Huang Q; Shi L; Fu J
    Front Aging Neurosci; 2022; 14():916633. PubMed ID: 35813943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peak Width of Skeletonized Mean Diffusivity as Neuroimaging Biomarker in Cerebral Amyloid Angiopathy.
    Raposo N; Zanon Zotin MC; Schoemaker D; Xiong L; Fotiadis P; Charidimou A; Pasi M; Boulouis G; Schwab K; Schirmer MD; Etherton MR; Gurol ME; Greenberg SM; Duering M; Viswanathan A
    AJNR Am J Neuroradiol; 2021 May; 42(5):875-881. PubMed ID: 33664113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peak width of skeletonized mean diffusivity in cerebral amyloid angiopathy: Spatial signature, cognitive, and neuroimaging associations.
    Zanon Zotin MC; Schoemaker D; Raposo N; Perosa V; Bretzner M; Sveikata L; Li Q; van Veluw SJ; Horn MJ; Etherton MR; Charidimou A; Gurol ME; Greenberg SM; Duering M; Dos Santos AC; Pontes-Neto OM; Viswanathan A
    Front Neurosci; 2022; 16():1051038. PubMed ID: 36440281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unveiling connections between venous disruption and cerebral small vessel disease using diffusion tensor image analysis along perivascular space (DTI-ALPS): A 7T MRI study.
    Zhang X; Pei X; Shi Y; Yang Y; Bai X; Chen T; Zhao Y; Yang Q; Ye J; Leng X; Yang Q; Bai R; Wang Y; Sui B
    Int J Stroke; 2024 Oct; ():17474930241293966. PubMed ID: 39402900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glymphatic Dysfunction Mediates the Influence of White Matter Hyperintensities on Episodic Memory in Cerebral Small Vessel Disease.
    Ke Z; Mo Y; Li J; Yang D; Huang L; Yang Z; Qin R; Mao C; Lv W; Huang Y; Hu Z; Zhang B; Xu Y
    Brain Sci; 2022 Nov; 12(12):. PubMed ID: 36552071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroimaging findings related to glymphatic system alterations in older adults with metabolic syndrome.
    Andica C; Kamagata K; Takabayashi K; Kikuta J; Kaga H; Someya Y; Tamura Y; Kawamori R; Watada H; Taoka T; Naganawa S; Aoki S
    Neurobiol Dis; 2023 Feb; 177():105990. PubMed ID: 36621631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Centrum Semiovale Perivascular Space and Amyloid Deposition in Spontaneous Intracerebral Hemorrhage.
    Tsai HH; Pasi M; Tsai LK; Huang CC; Chen YF; Lee BC; Yen RF; Gurol ME; Jeng JS
    Stroke; 2021 Jul; 52(7):2356-2362. PubMed ID: 33874751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Hippocampal Volumes and Cognition in Cerebral Amyloid Angiopathy.
    Perosa V; Zanon Zotin MC; Schoemaker D; Sveikata L; Etherton MR; Charidimou A; Greenberg SM; Viswanathan A
    Neurology; 2024 Jan; 102(2):e207854. PubMed ID: 38165326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markers.
    Jang H; Jang YK; Kim HJ; Werring DJ; Lee JS; Choe YS; Park S; Lee J; Kim KW; Kim Y; Cho SH; Kim SE; Kim SJ; Charidimou A; Na DL; Seo SW
    Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1287-1298. PubMed ID: 30937462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofilament light chain predicts risk of recurrence in cerebral amyloid angiopathy-related intracerebral hemorrhage.
    Cheng X; Su Y; Wang Q; Gao F; Ye X; Wang Y; Xia Y; Fu J; Shen Y; Al-Shahi Salman R; Dong Q
    Aging (Albany NY); 2020 Nov; 12(23):23727-23738. PubMed ID: 33221749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.